INTEGRAGEN (ALINT.PA) Fundamental Analysis & Valuation

EPA:ALINT • FR0010908723

Current stock price

0.168 EUR
+0.01 (+3.7%)
Last:

This ALINT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALINT.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALINT has reported negative net income.
  • In the past 5 years ALINT reported 4 times negative net income.
  • In the past 5 years ALINT always reported negative operating cash flow.
ALINT.PA Yearly Net Income VS EBIT VS OCF VS FCFALINT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 0 -500K -1M -1.5M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -42.94%, ALINT is doing worse than 60.49% of the companies in the same industry.
  • The Return On Equity of ALINT (-442.86%) is worse than 65.43% of its industry peers.
Industry RankSector Rank
ROA -42.94%
ROE -442.86%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALINT.PA Yearly ROA, ROE, ROICALINT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

  • ALINT has a Gross Margin (59.49%) which is in line with its industry peers.
  • ALINT's Gross Margin has declined in the last couple of years.
  • ALINT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-1.96%
ALINT.PA Yearly Profit, Operating, Gross MarginsALINT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALINT.PA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ALINT remains at a similar level compared to 1 year ago.
  • ALINT has more shares outstanding than it did 5 years ago.
  • ALINT has a better debt/assets ratio than last year.
ALINT.PA Yearly Shares OutstandingALINT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M
ALINT.PA Yearly Total Debt VS Total AssetsALINT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • Based on the Altman-Z score of -0.76, we must say that ALINT is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -0.76, ALINT is not doing good in the industry: 60.49% of the companies in the same industry are doing better.
  • ALINT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.76
ROIC/WACCN/A
WACCN/A
ALINT.PA Yearly LT Debt VS Equity VS FCFALINT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 1M 2M 3M

2.3 Liquidity

  • A Current Ratio of 1.04 indicates that ALINT should not have too much problems paying its short term obligations.
  • ALINT has a worse Current ratio (1.04) than 75.31% of its industry peers.
  • ALINT has a Quick Ratio of 1.04. This is a bad value and indicates that ALINT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.96, ALINT is not doing good in the industry: 72.84% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.96
ALINT.PA Yearly Current Assets VS Current LiabilitesALINT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ALINT.PA Growth Analysis

3.1 Past

  • The earnings per share for ALINT have decreased strongly by -2200.00% in the last year.
  • The Revenue for ALINT has decreased by -39.29% in the past year. This is quite bad
  • Measured over the past years, ALINT shows a small growth in Revenue. The Revenue has been growing by 0.99% on average per year.
EPS 1Y (TTM)-2200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-950%
Revenue 1Y (TTM)-39.29%
Revenue growth 3Y-8.41%
Revenue growth 5Y0.99%
Sales Q2Q%-43.98%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALINT.PA Yearly Revenue VS EstimatesALINT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M 10M
ALINT.PA Yearly EPS VS EstimatesALINT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 -0.1 -0.2 -0.3

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALINT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALINT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALINT.PA Price Earnings VS Forward Price EarningsALINT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALINT.PA Per share dataALINT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALINT.PA Dividend Analysis

5.1 Amount

  • No dividends for ALINT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALINT.PA Fundamentals: All Metrics, Ratios and Statistics

INTEGRAGEN

EPA:ALINT (4/23/2026, 7:00:00 PM)

0.168

+0.01 (+3.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-20
Earnings (Next)06-30
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.13M
Revenue(TTM)6.69M
Net Income(TTM)-1.55M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 3.23
P/tB 3.23
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.99
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -42.94%
ROE -442.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.49%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-1.96%
F-ScoreN/A
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.04
Quick Ratio 0.96
Altman-Z -0.76
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-950%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-39.29%
Revenue growth 3Y-8.41%
Revenue growth 5Y0.99%
Sales Q2Q%-43.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1228.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

INTEGRAGEN / ALINT.PA Fundamental Analysis FAQ

What is the fundamental rating for ALINT stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALINT.PA.


Can you provide the valuation status for INTEGRAGEN?

ChartMill assigns a valuation rating of 0 / 10 to INTEGRAGEN (ALINT.PA). This can be considered as Overvalued.


Can you provide the profitability details for INTEGRAGEN?

INTEGRAGEN (ALINT.PA) has a profitability rating of 0 / 10.


What is the financial health of INTEGRAGEN (ALINT.PA) stock?

The financial health rating of INTEGRAGEN (ALINT.PA) is 4 / 10.